Attributes | Values |
---|
rdf:type
| |
Description
| - Two hundred nine patients with active rheumatoid arthritis, who were receiving methotrexate for at least 6 months, were randomized in a double-blind fashion to receive: placebo and three doses of interferon-? administered in subcutaneous injections for the duration of 24 weeks. At the doses tested, treatment with IFN-3 times weekly did not induce a clinical or radiological effect in RA patients
- Two hundred nine patients with active rheumatoid arthritis, who were receiving methotrexate for at least 6 months, were randomized in a double-blind fashion to receive: placebo and three doses of interferon-? administered in subcutaneous injections for the duration of 24 weeks. At the doses tested, treatment with IFN-3 times weekly did not induce a clinical or radiological effect in RA patients (en)
|
Title
| - A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis
- A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (en)
|
skos:prefLabel
| - A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis
- A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (en)
|
skos:notation
| - RIV/00023728:_____/05:00000230!RIV10-MZ0-00023728
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00023728:_____/05:00000230
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - multicentre; randomised; double; blind; placebo; controlled; phase; study; subcutaneous; interferon; beta-1a; treatment; patients; active; rheumatoid; arthritis (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Annals of Rheumatic Diseases
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Pavelka, Karel
- Rozman, B.
- Vencovský, Jiří
- Tak, P. P.
- Herrero-Beaumont, G.
- Alvaro, J.
- Furst, D.
- Genovese, M.
- Kivitz, A. J.
- McInnes, I. B.
- Musikic, P.
- Nuki, G.
- Stahl, H.
- Van Holten, J.
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |